Advertisement ICON chooses Oracle Health Sciences LabPas solution for Phase I clinical trials - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

ICON chooses Oracle Health Sciences LabPas solution for Phase I clinical trials

ICON has chosen the Oracle Health Sciences LabPas solution, delivered via the Oracle Health Sciences Cloud, to support subject recruitment, data capture and analysis, and enhance clinical workflows for its Phase I clinical trials.

Oracle claims Health Sciences LabPas helps to manage the workflow and offer real-time access to data.

ICON is a provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries.

ICON said Oracle Health Sciences LabPas solution help ICON automate its early phase clinical trial processes and better integrate Phase I data with its existing clinical data capture and management systems.

ICON Development Solutions president Thomas Frey said by automating their entire Phase I processes, Oracle Health Sciences LabPas puts us at the forefront of early-phase research as they help clients turn data into actionable knowledge quicker than ever before.